Blueprint Medicines Market Cap

FRA:31S has a market cap or net worth of €1.42 billion as of August 1, 2025. Its market cap has decreased by -1.90% in one year.

Market Cap

1.42B

Enterprise Value

1.08B

Revenue

1.49B

Ranking

n/a

PE Ratio

8.60

Stock Price

$1.74

Market Cap Chart

Since August 31, 2007, FRA:31S's market cap has increased from 878.08M to 1.42B, an increase of 61.80%. That is a compound annual growth rate of 2.72%.

Market Cap History

Date	Market Cap	% Change
Aug 1, 2025	1.43B	-14.13%
Dec 31, 2024	1.67B	97.35%
Dec 29, 2023	846.15M	21.10%
Dec 30, 2022	698.74M	-16.99%
Dec 31, 2021	841.72M	11.82%
Dec 31, 2020	752.75M	-33.62%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	289.34B
Siemens Aktiengesellschaft	176.66B
Deutsche Telekom AG	154.36B
Allianz SE	131.75B
Rheinmetall AG	79.50B
Siemens Energy AG	77.36B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	74.55B
Deutsche Bank Aktiengesellschaft	54.97B

Market Cap Rankings